April 3 (Reuters) - MoonLake Immunotherapeutics MLTX.O:
MOONLAKE SECURES UP TO $500 MILLION IN NON-DILUTIVE FINANCING FROM HERCULES CAPITAL AND ANNOUNCES A CAPITAL MARKETS UPDATE ON APRIL 29 TO PROVIDE IMPORTANT CLINICAL UPDATES
Source text: ID:nGNX5nzGGx
Further company coverage: MLTX.O
((Reuters.Briefs@thomsonreuters.com;))